So, A. C. P., Denholm, M., Robinson, S. D., Monaca, F., Kidd, A., Smith, P., Whithey, D., Abdelaziz, M., Lalwani, S., Alsayed, A., Gul, R., Thomas, D., Sattar, A., Bawany, S., Aujayeb, A., Bolnykh, I., Fathima, K., Eeckelaers, S., Perez, P. M., Januszewski, A. (2026). Early mortality in patients with advanced non–small cell lung cancer (aNSCLC) and PD-L1 ≥ 50% receiving first-line immune checkpoint inhibitor (ICI): Analysis of the NOTCH collaborative REAL-SAIF study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20684